Brief: Avrobio Determines No Material Charges Expected To Incur With Cystinosis Gene Therapy Program Sale
14/06/2023 22:39
June 14 (Reuters) - AVROBIO Inc AVRO.O :
* AVROBIO- DETERMINES NO MATERIAL CHARGES ARE EXPECTED TO
BE
INCURRED IN CONNECTION WITH CYSTINOSIS GENE THERAPY PROGRAM SALE
& RELATED ASSETS SALE
Further company coverage: AVRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs